Israel-based biomedical company Nurami Medical has raised US$30 million in its latest funding round. The funds will help expand its workforce and scale operations, including the construction of a commercial manufacturing facility, research and development lab, and clean rooms for producing its first FDA-approved product. Nurami develops products for neurological surgeries, specifically addressing cerebrospinal fluid leakage.
Israeli biomedical firm Nurami bags $30m
